Furthermore, studies have shown that AID can promote and accumulate the same gene mutations in the TCL1 and Eμ-TCL1 mouse models, also in human chronic lymphocytic leukemia (CLL) patients. The gene discussed is AICDA; the disease is B-cell chronic lymphocytic leukemia.